This Best Practice in Study Feasibility report covers techniques and innovations proffered by sponsors and CROs for conducting feasibility analyses.
Successfully navigating the medical, clinical, logistical and regulatory challenges associated with establishing the feasibility of a clinical trial is not easy. Insights from sponsor organizations, CROs and sites have been compiled in ISR’s Best Practices in Study Feasibility report. A particular area of interest for readers of the report are the techniques and innovations proffered by sponsors and CROs for conducting feasibility analyses. Both groups identified that the integration of statistical modeling and knowledge of past performance into feasibility analyses is positively impacting the process. Sponsors also see value in making direct, personal contact with investigators to build better relationships and a greater use of EMR data as positive innovations. CROs point to improved feasibility surveys and better targeting questions as ways to improve study feasibility estimations. “In terms of a feasibility analysis, what are some of the best techniques or innovations you have experienced? Please be as specific as possible. Thank you.” (Sponsor n=60, CROs n=18)
In addition to findings on the top techniques and innovations used when conducting a feasibility analysis, ISR has collected additional insights to improve the accuracy of study feasibility estimates in its Best Practices in Study Feasibility report, including:
The
Best Practices in Study Feasibility
report is a useful tool for all parties involved in study feasibility estimations, whether at the sponsor organization, CRO, specialized feasibility firm or site. The report will aid readers in knowing the most effective techniques and innovations used to establish accurate feasibility estimates, when to consider engaging a specialized feasibility analysis firm and how to implement the best practices used by industry peers. For more information about the report, please visit ISR’s report page at
https://www.isrreports.com/reports/best-pratices-in-study-feasibility/
.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.